2021/2 GaBI Journal Table of Contents

Contents

Editor’s Letter

What to look forward to in GaBI Journal, 2021, Issue 2

Original Research

Summative usability evaluation of the YLB113 etanercept biosimilar autoinjector via simulation

Biosimilars in Saudi Arabia: a single-centre, open-label case series examining infliximab switching

Variation in the prices of oncology medicines across Europe and the implications for the future

Review Article

The EU regulatory network and emerging trends – a review of quality, safety and clinical development programmes

An overview of the current status of follow-on biologicals in Iran

Abstracted Scientific Content

Repurposing non-oncology drugs for cancer treatment

Source URL: https://gabi-journal.net/2021-2-gabi-journal-table-of-contents.html